Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05432830 · ClinicalTrials.gov registry record · NA
Sex Differences in E-cig Perception: Study 1
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT05432830: Completed NA study, sponsored by Yale University.
NCT05432830 is a NA study that has completed, run by Yale University. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05432830, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The primary objective is to examine the influence of sex on sensory effects, appeal, and reinforcing value of nicotine containing e-cigs in popular flavor components; sweet and cooling.
Primary Outcome
Change in appeal at each flavor as measured by the computerized Labeled Hedonic Scale (LHS). Participants will self-report their responses using a computer mouse to indicate where on the scale response falls. The Labeled Hedonic Scale (LHS) is a bipolar category ratio scale that ranges from -100 (most disliked) to 100 (most liked), with 'neither liked nor disliked' as midpoint.
Interventions
- OTHER E-liquid Flavor 1
- OTHER E-liquid Flavor 2
- OTHER E-liquid Flavor 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2024-04-30 |
| Est. Completion | 2025-07-18 |
| Phase | NA |
What the finished NCT05432830 record still lists
NCT05432830 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which E-liquid Flavor 1 is the first listed.
NCT05432830 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05432830 about?
NCT05432830 is a clinical study titled "Sex Differences in E-cig Perception: Study 1". The primary objective is to examine the influence of sex on sensory effects, appeal, and reinforcing value of nicotine containing e-cigs in popular flavor components; sweet and cooling.
What is the current status of trial NCT05432830?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2024-04-30. Estimated completion is 2025-07-18.
What interventions are being tested in trial NCT05432830?
The interventions under investigation include: E-liquid Flavor 1 (OTHER), E-liquid Flavor 2 (OTHER), E-liquid Flavor 3 (OTHER).
Who is sponsoring clinical trial NCT05432830?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05432830's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI